Sign Up Today and Learn More About K36 Therapeutics Stock
Invest in or calculate the value of your shares in K36 Therapeutics or other pre-IPO companies through EquityZen's platform.
K36 Therapeutics Stock (KTST)
K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.
About K36 Therapeutics Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
K36 Therapeutics Press Mentions
Stay in the know about the latest news on K36 Therapeutics
Substituted piperidinyl-methylpurine pyridines and related compounds and their …
patents • Apr 02, 2025
Carbohydrate-functionalized piperidinyl-methylpurine pyridines and related …
patents • Apr 02, 2025
Heterobicyclic-methylpurine pyridines and related compounds and their use in …
patents • Apr 02, 2025
Deuterium-enriched piperidinyl-methyl-purine amines and related compounds and …
patents • Feb 09, 2025
Pharmaceutical compositions containing a piperidinyl-methyl-purine amine and …
patents • Feb 09, 2025
K36 Therapeutics Management
Leadership team at K36 Therapeutics
Board of Directors
Chong Xu
Board of Directors
Melissa McCracken
Join now and verify your accreditation status to gain access to:
- K36 Therapeutics Current Valuation
- K36 Therapeutics Stock Price
- K36 Therapeutics Management
- Available deals in K36 Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- K36 Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- K36 Therapeutics Revenue and Financials
- K36 Therapeutics Highlights
- K36 Therapeutics Business Model
- K36 Therapeutics Risk Factors
- K36 Therapeutics Research Report from SACRA Research
Trading K36 Therapeutics Stock
How to invest in K36 Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like K36 Therapeutics through EquityZen funds. These investments are made available by existing K36 Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell K36 Therapeutics stock?
Shareholders can sell their K36 Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
